Cardiome Corrals Correvio, Gains Cash for Brinavess
By Marie Powers
Tuesday, November 19, 2013
Cardiome Pharma Corp. and privately held specialty pharma Correvio LLC consummated a marriage of convenience that may create a company stronger than the sum of the two partners. Correvio, based in Geneva, markets the single product Aggrastat (tirofiban HCL) to cardiologists in more than 60 countries, generating annual revenues of approximately $30 million.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.